Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANS Alterations During Smoking Cessation
NCT01474265Phase 4Completed
- Sponsor
- Institut für anwendungsorientierte Forschung und klinische Studien
- Start
- Nov 2011
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline, nicotine in nicotine dependence, sponsored by Institut für anwendungsorientierte Forschung und klinische Studien. Started Nov 2011; status: completed.
02
Drugs
vareniclinenicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT01474265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01474265.